Novavax Inc (NASDAQ:NVAX)

16.52
Delayed Data
As of Dec 02
 -0.33 / -1.96%
Today’s Change
15.53
Today|||52-Week Range
236.50
-88.45%
Year-to-Date
Novavax (NVAX) COVID Jab Gets Expanded Label in WHO's EUL
Nov 30 / Zacks.com - Paid Partner Content
Investors Heavily Search Novavax, Inc. (NVAX): Here is What You Need to Know
Nov 25 / Zacks.com - Paid Partner Content
Do Options Traders Know Something About Novavax (NVAX) Stock We Don't?
Nov 30 / Zacks.com - Paid Partner Content
Novavax Stock: Buy, Sell, or Hold in 2023?
Nov 24 / MotleyFool.com - Paid Partner Content
Novavax (NVAX) Stock Nosedives 88% This Year: Here's Why
Nov 28 / Zacks.com - Paid Partner Content
Novavax (NVAX) Cancels COVID Jab Supply Deal With GAVI
Nov 23 / Zacks.com - Paid Partner Content
Is Novavax Stock a Buy Now?
Nov 26 / MotleyFool.com - Paid Partner Content
Why Shares of Novavax Are Down Tuesday
Nov 22 / MotleyFool.com - Paid Partner Content
3 Potentially Explosive Stocks to Buy Before 2023
Nov 26 / MotleyFool.com - Paid Partner Content
Nasdaq Bear Market: 3 Remarkable Growth Stocks Down Over 90% That Can Double Your Money by 2025
Nov 22 / MotleyFool.com - Paid Partner Content

Today’s Trading

Previous close16.85
Today’s open16.50
Day’s range15.54 - 16.52
Volume174,799
Average volume (3 months)5,138,128
Market cap$1.2B
Data as of 3:59pm ET, 12/02/2022

Growth & Valuation

Earnings growth (last year)-222.51%
Earnings growth (this year)+69.97%
Earnings growth (next 5 years)+58.18%
Revenue growth (last year)+141.02%
P/E ratioNM
Price/Sales9.29
Price/Book--

Competitors

 Today’s
change
Today’s
% change
TVTXTravere Therapeutics...+0.52+2.66%
----
ALLOAllogene Therapeutic...+0.09+0.91%
QUREUniqure NV-0.26-0.99%
Data as of 4:00pm ET, 12/02/2022

Financials

Next reporting dateFebruary 27, 2023
EPS forecast (this quarter)-$1.10
Annual revenue (last year)$1.1B
Annual profit (last year)-$1.7B
Net profit margin-152.12%

Profile

Sector
Health Technology
Industry
Biotechnology
No executives to display
Corporate headquarters
Gaithersburg, Maryland

Forecasts